Technical Analysis for NEO - NeoGenomics, Inc.

Grade Last Price % Change Price Change
grade F 19.72 -1.15% -0.23
NEO closed down 1.15 percent on Wednesday, October 23, 2019, on 84 percent of normal volume.

Earnings due: Oct 29

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical NEO trend table...

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Multiple of Ten Bearish Other 0.00%
Bollinger Band Squeeze Range Contraction -1.15%
Multiple of Ten Bearish Other -1.15%
Overbought Stochastic Strength -1.15%
Stochastic Sell Signal Bearish -3.00%
Bollinger Band Squeeze Range Contraction -3.00%
Weak + Overbought Other -3.00%
BB Squeeze Started Range Contraction -3.00%

Older signals for NEO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
NeoGenomics, Inc., together with its subsidiary, NeoGenomics Laboratories, Inc., operates a network of cancer-focused testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. The company performs analyses for hematopoietic cancers, such as leukemia and lymphoma; and solid tumor cancers comprising breast, lung, colon, and bladder cancer. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry testing services to identify cell proteins in a tissue section; and molecular testing services that focus on the analysis of DNA and RNA, as well as on the structure and function of genes at the molecular level. The company's trademarks include NeoFISH, NeoFlow, NeoSITE, NeoArray, NeoType, and MelanoSITE. NeoGenomics, Inc. was founded in 2001 and is headquartered in Fort Myers, Florida.
Cancer Biology Diseases Genetics Lymphoma Medical Tests Leukemia Anatomical Pathology Laboratory Techniques Bladder Cancer Solid Tumor Cancers Hybridization Cytogenetics Fluorescence In Situ Hybridization
Is NEO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 26.85
52 Week Low 11.05
Average Volume 742,932
200-Day Moving Average 21.09
50-Day Moving Average 22.0012
20-Day Moving Average 19.767
10-Day Moving Average 20.022
Average True Range 0.7005
ADX 25.75
+DI 17.4899
-DI 27.8801
Chandelier Exit (Long, 3 ATRs ) 19.6785
Chandelier Exit (Short, 3 ATRs ) 20.6215
Upper Bollinger Band 20.6477
Lower Bollinger Band 18.8863
Percent B (%b) 0.47
BandWidth 8.910811
MACD Line -0.4436
MACD Signal Line -0.6108
MACD Histogram 0.1672
Fundamentals Value
Market Cap 1.57 Billion
Num Shares 79.4 Million
EPS -0.33
Price-to-Earnings (P/E) Ratio -59.76
Price-to-Sales 2.72
Price-to-Book 4.01
PEG Ratio 3.28
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 20.71
Resistance 3 (R3) 20.72 20.41 20.55
Resistance 2 (R2) 20.41 20.15 20.40 20.49
Resistance 1 (R1) 20.06 20.00 19.91 20.05 20.43
Pivot Point 19.75 19.75 19.67 19.74 19.75
Support 1 (S1) 19.40 19.49 19.25 19.39 19.01
Support 2 (S2) 19.09 19.34 19.08 18.95
Support 3 (S3) 18.74 19.09 18.90
Support 4 (S4) 18.73